GLP-1 medications show promise in reducing chemotherapy side effects and improving heart health in breast cancer patients, warranting further research.
Elvis Obomanu, MBBS, LMCC
Advertisement
Articles by Elvis Obomanu, MBBS, LMCC
Explore the pleiotropic effects of GLP-1 agents in oncology care, highlighting their benefits and considerations for pharmacists and clinicians.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
2
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
3
FDA Expanded Approval of Imiglucerase Expands Treatment Options for Type 3 Gaucher Disease
4
New AHA Scientific Statement Notes Socioeconomic, Structural Barriers to Addressing Obesity
5